The Effects of Administration of Exogenous Albumin Early after Non-cardiac Surgery on Postoperative AKI in Patients with Preoperative Hypoalbuminemia: A Prospective Propensity-score Matching Analysis

The Effects of Administration of Exogenous Albumin Early after Non-cardiac Surgery on Postoperative AKI in Patients with Preoperative Hypoalbuminemia: A Prospective Propensity-score Matching Analysis | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article The Effects of Administration of Exogenous Albumin Early after Non-cardiac Surgery on Postoperative AKI in Patients with Preoperative Hypoalbuminemia: A Prospective Propensity-score Matching Analysis Miao Yan, Wei-Jie Zhou, Min Xie, Sai-Nan Zhu, Nan Li, Shuang-Ling Li This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-1131516/v2 This work is licensed under a CC BY 4.0 License Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Abstract Background: Evidence has shown that preoperative hypoalbuminemia is independently associated with acute kidney injury (AKI) after non-cardiac surgery. However, little study has investigated the effects of administration of exogenous albumin early after non-cardiac surgery on postoperative AKI in patients with preoperative hypoalbuminemia. Methods: This study was a secondary analysis of the database of a previously conducted prospective cohort study. Data of 661 adult patients who underwent non-cardiac surgery and were admitted to Surgical Intensive Care Unit (SICU) after surgery from May 1, 2019, to November 30, 2020, were collected. 267 patients with preoperative hypoalbuminemia were screened, and divided into two groups according to whether they were administrated with exogenous albumin on the day of SICU admission. The demographic and perioperative data of the two groups were propensity-matched. Results： After propensity score matching, 64 pairs of patients were included in the final analysis. The patients of the albumin group showed a higher serum albumin level on postoperative day 1 than that in patients of the control group [31.3±3.4 vs. 29.7±3.8, P =0.008], however, no difference was observed in postoperative AKI incidence between the two groups (59.4% vs. 62.5%, P =0.717). Furthermore, there was no difference in other prognostic factors, such as the use and duration of mechanical ventilation, number of other postoperative complications, in-hospital mortality, length of SICU stay and postoperative hospital stay. Conclusions: The current study did not exhibit benefit of exogenous albumin administration early after non-cardiac surgery on the occurrence of postoperative AKI in patients with preoperative hypoalbuminemia, which needs to be confirmed by further large randomized controlled researches in the future. Hypoalbuminemia Acute kidney injury Exogenous albumin infusion Figures Figure 1 Introduction Acute kidney injury (AKI) is a common complication after surgery among different patient populations, and postoperative AKI is associated with poor outcomes[1]. In the absence of proven effective treatments for AKI, early recognition of modifiable risk factors and the development of renal protective strategies would be beneficial. Perioperative hypoalbuminemia has proved to be a risk factor for increased incidence of postoperative AKI[2-7]. Renal protective properties of albumin have been shown in amount of clinical and basic studies[8-11]. Serum albumin may play a protective role in the maintenance of effective circulating volume and renal perfusion, preservation of proximal tubular integrity and function, binding of endogenous toxins and nephrotoxic drugs, scavenging and limiting the production of reactive oxygen species, and delivery of protective lysophosphatidic acid. In addition, albumin can improve microcirculatory blood flow and reduce the inflammatory response. In our previous study, a preoperative serum albumin level of less than 37.5g/L was found to be independently associated with postoperative AKI in patients undergoing non-cardiac surgery[2]. We suppose that correction of hypoalbuminemia may be a reasonable preventive strategy for postoperative AKI. Although administration of exogenous albumin for correcting hypoalbuminemia has been widely used in various clinical settings, there are limited data on whether perioperative albumin intravenous infusion affects the occurrence of postoperative AKI, and its usefulness for organ protection is still a matter of debate[12]. This study was conducted to prospectively evaluate the effect of administration of exogenous albumin early after surgery on postoperative AKI occurrence in patients with preoperative hypoalbuminemia following non-cardiac surgery. Methods Ethics and consent This study was a secondary analysis of the database of a previously conducted prospective cohort study investigating the perioperative predictors of AKI following non-cardiac surgery. Ethical approval (2019-075) was provided by the Clinical Research Ethics Committee of Peking University First Hospital. The privacy rights of participants were observed. The original study was conducted in the Surgical Intensive Care Units (SICU) of Peking University First Hospital from May 1, 2019, to November 30, 2020. Written informed consents were obtained from patients, their next of kin or their legal representatives. Patients The inclusion criteria included (1) adult patients (age≥18 years), (2) undergoing non-cardiac surgery, and (3) being admitted to SICU immediately after surgery. Patients with any of the following criteria were excluded: (1) preoperative chronic kidney disease stage 5 or requiring long-term dialysis; (2) surgery involving kidney, such as nephrectomy, partial nephrectomy, nephroureterectomy, or kidney transplantation; (3) AKI events before admission to SICU; (4) without Foley catheter placement; and (5) written informed consent not obtained. Our medical center is a teaching hospital affiliated with a university, which provides tertiary care and has about 1600 beds. Data collection Specially trained researchers were responsible for patient recruitment and data collection. The data of patients were collected from the electronic medical records system of our hospital. Preoperative information included demographic characteristics (age, gender), body mass index (BMI), medical history, nephrotoxin exposure, American Society of Anesthesiology (ASA) Classification of Physical Status, as well as preoperative clinical laboratory data. Intraoperative data included type and duration of surgery, surgical approach, anesthesia method, duration of anesthesia, fluid input and output, estimated blood loss, occurrence of hypotension and duration, and use of vasoactive drugs. Postoperative data included non-renal Sequential Organ Function Assessment (SOFA) score within 24h of SICU admission and sepsis on SICU admission. Definition and outcomes The cutoff value of preoperative hypoalbuminemia was 37.5g/L, which referred to our previous research reporting that preoperative serum albumin level less than 37.5g/L was an independent risk factor for AKI after non-cardiac surgery[2]. The timing of early administration of exogenous albumin was defined as being less than 12 hours after surgery. In our department, 20% albumin is generally administrated either in patients who require persist fluid resuscitation, or in patients who need to maintain a high colloidal osmotic pressure, such as patients with intracranial hypertension or a very low albumin level[13]. Postoperative follow-up was performed. The primary end point was postoperative AKI development. Postoperative AKI were defined according to Kidney Disease Improving Global Outcomes (KDIGO) criteria using the maximal change in serum creatinine compared with the preoperative baseline values and urine output during the first 7 postoperative days[14]. The secondary end points were the amount of early albumin infusion, the level of serum albumin on postoperative day 1, positive fluid balance on the day of SICU admission, postoperative use and duration of mechanical ventilation (MV), length of stay in SICU and hospital after surgery, occurrence of postoperative complications other than AKI, and in-hospital mortality. Other main postoperative complications were pulmonary infection, pleural effusion, pulmonary atelectasis, respiratory failure, surgical bleeding, new-onset arrhythmia, acute myocardial infarction, hemodynamic insufficiency, stroke, ileus, anastomotic leakage, intra-abdominal abscess, acute liver injury, wound infection, wound dehiscence, urinary tract infection, sepsis, disseminated intravascular coagulation, digestive tract bleeding, and venous thromboembolism (Table S1). Statistical analysis The Kolmogorov-Smirnov method was used to test the normality of continuous variables. Normally distributed data were presented as mean ± standard deviation (SD), and non-normally distributed data were presented as median (minimum-maximum). Categorical variables were presented as number (percentage). Analyses of the frequencies of categorical variables were performed using chi-squared test or Fisher’s exact test. Differences in quantitative variables between two independent groups were tested with t-test or Mann–Whitney U test. Several underlying susceptibilities, procedures, or exposures have been identified as risk factors of postoperative AKI occurrence[3, 15].Variables being considered clinically relevant were used for propensity score matching and selected a priori. These variables included age, gender, BMI, preoperative comorbidities, preoperative and postoperative albumin, ASA classification, type and duration of surgery, type and duration of anesthesia, intraoperative hemodynamic instability and postoperative non-renal SOFA. The propensity score matching was conducted using multivariate logistic regression. Patients were matched in a 1:1 ratio based on their scores using the nearest-neighbor matching with the tolerance being 0.1. Between-group differences of baseline and perioperative variables for propensity score matching were compared using the absolute standardized differences (ASDs)[16], which were calculated as (mean1-mean2)/SD1. An ASD ≥0.250 was considered imbalanced between the two groups. Data analyses were performed with SPSS 26.0. Two-tailed P values lower than 0.05 were considered statistically significant. Results Participants During the enrollment period, a total of 661 patients who underwent non-cardiac surgery and were admitted to SICU met the inclusion/exclusion criteria. Of the 247 patients with preoperative hypoalbuminemia, 130 received administration of 20% albumin early after surgery (albumin group), with 25 (19.2%) receiving albumin for hemodynamic stabilization and improving organ perfusion, 70 (53.8%) receiving albumin to maintain high colloid osmolarity, and 35 (26.9%) receiving albumin for the both aims. The amounts of the received albumin were 20 (10-100) gram, 20 (10-150) gram and 30 (10-50) gram, respectively. The remaining 117 did not receive postoperative early albumin infusion (control group). Propensity score matching was performed to match the baseline and perioperative variables. Ultimately, 64 pairs of patients were included in the final statistical analysis. Figure 1 showed the flow diagram of the study. Baseline and perioperative data In this study, the baseline and perioperative data of the 247 patients with preoperative hypoalbuminemia were analyzed. Compared with patients of the control group, those of the albumin group had more history of coronary heart disease, more ACEI/ARB medication history, lower preoperative and postoperative albumin; they underwent more abdominopelvic surgery and general anesthesia; they had longer duration of surgery and anesthesia; they received more fluids during surgery; they showed more intraoperative hypotension and received more vasoactive drugs; they had higher non-renal SOFA within 24h of SICU admission and more sepsis on SICU admission. After propensity score matching, the above variables of the two groups were well balanced (Tables 1-3). Primary and secondary endpoints The patients of the albumin group were administrated with 20 (10-150) gram albumin early after surgery, and serum albumin on postoperative day 1 in patients of the albumin group was higher than that in patients of the control group [31.3±3.4 vs. 29.7±3.8, P =0.008], which indicated that administration of albumin early after surgery did improve the albumin level on postoperative day 1. However, there was no difference in postoperative AKI incidence between the two groups (59.4% vs. 62.5%, P =0.717). Furthermore, higher positive fluid balance on the day of SICU admission was observed in the albumin group, but not statistically significant [36.5 (4.0-337.0) vs. 32.0 (4.0-128.0), P =0.064] (Table 4). Regarding other secondary end points, no difference was found in the use and duration of MV, number of other postoperative complications, in-hospital mortality and postoperative hospital stay between the two groups (Table 4). Particularly, the tendency of longer duration of SICU stay in the albumin group was noticed, although no statistical difference was observed [2.0 (1.0-23.0) vs. 1.0 (1.0-66.0), P =0.090]. As for postoperative complications, the rate of sepsis seemed to be higher in patients of the albumin group (18.8% vs. 6.3%, P =0.059] (Table S1). One of the most common organs affected by sepsis is the kidney, resulting in sepsis associated AKI that contributes to the morbidity and mortality of sepsis[17]. Sepsis associated AKI was diagnosed in 6 (9.4%) patients of the albumin group, and 2 (3.1%) patients of the control group ( P =0.273). Besides, the rate of acute myocardial infarction was found to be higher in patients of the albumin group (9.4% vs. 0.0%, P =0.028) (Table S1). Discussion In this study, we prospectively analyzed the association between administration of exogenous albumin early after non-cardiac surgery and postoperative AKI in patients with preoperative hypoalbuminemia. Although the patients of the albumin group exhibited a higher serum albumin level on postoperative day 1, no differences were observed in postoperative AKI occurrence and other prognostic factors between the two groups. Cumulative evidence has shown that a perioperatively reduced serum albumin level may contribute to an increased risk of postoperative AKI in various clinical settings[1-4, 6, 7]. There are several factors responsible for the changes in albumin concentration after surgery: (1) Large amounts of fluid infusion during the operation leads to the dilution of plasma albumin; (2) The ability of liver to synthesize albumin decreases under stress; (3) Decomposition of albumin is increased to compensate for energy expenditure under stress; (4) The permeability of capillaries increases in the systemic inflammatory responses, and plasma albumin molecules leak out from the blood vessels; (5) Albumin is lost with blood loss during surgery. Among the above factors, the blood dilution and the exudation of albumin molecules out of the capillaries were considered to be the main causes of postoperative hypoalbuminemia[18, 19]. Currently, the conclusions of limited studies investigating the effect of perioperative exogenous albumin infusion on occurrence of postoperative AKI are not consistent. Eun-Ho Lee et al. prospectively reported that administration of exogenous albumin immediately before surgery reduced the risk of AKI after off-pump coronary artery bypass surgery in patients with a preoperative serum albumin level of less than 4.0 g/dl, although the observed difference in that study was only marginally significant ( P =0.048)[12]. On the contrary, in the retrospective cohort study of Anne Julie Frenette et al, a dose-dependent AKI risk associated with the administration of albumin until 36 hours after surgery was observed in patients undergoing on-pump cardiac surgery[20]. To the best of our knowledge, this is the first prospective cohort study investigating the association of albumin infusion early after non-cardiac surgery and incidence of postoperative AKI. In our study, there was no difference in occurrence of postoperative AKI in patients of the two groups, which did not show improvement of administration of exogenous albumin early after non-cardiac surgery on renal outcome. Several reasons were supposed to be responsible for the result. As mentioned above, surgery and the systemic inflammatory responses increase capillary permeability significantly, and massive albumin molecules leak out of the capillaries into the interstitial space, so the effect of correcting the hypoalbuminemia and the renal protective properties of serum albumin would not sustained. From this perspective, administration of exogenous albumin early after surgery, especially for major abdominopelvic surgery, is cost and unhelpful. On the contrary, with the subsidence of systemic inflammatory responses and the optimization of nutritional status, the level of serum albumin tends to recover spontaneously[21]. Additionally, in our study, although exogenous albumin was administrated early after surgery, the level of serum albumin in more than 89% of the patients was still lower than the threshold value, and the possibility that the dosage of exogenous albumin might not be sufficient could not be excluded completely. Furthermore, the causes of postoperative AKI are complicated and multifactorial. The isolated procedure of postoperative administration of exogenous albumin may not be enough to inhibit the pathological process leading to AKI in these high-risk patients. As for the secondary outcomes, the rate of sepsis seemed to be higher in patients of the albumin group (Table S1). This difference was supposed to be relevant to the higher rate of abdominopelvic surgery (67.2% vs. 57.8%) and open surgery (54.7% vs. 39.1%) in patients of the albumin group (Table 2-3), which predisposed patients to a high risk of infection. Meanwhile, despite propensity score was matched between the two groups, there might be some confounding factors that have not been well balanced and a selective bias might exist. For sepsis associated AKI, there was no statistical difference between the two groups. The incidence rate of acute myocardial infarction was found to be higher in the albumin group (Table S1), which might be explained by the higher rate of preoperative T2DM (28.1% vs. 23.4%) (Table 1) and postoperative sepsis (18.8% vs. 6.3%) in this group of patients. Specially, the higher incidence rates of postoperative complications mentioned above were also the main factors that were responsible for the longer SICU stay in these patients (Table 4). There are several other shortcomings in this study. Firstly, the standard of timing and dosage of albumin administration was absent. A definite treatment regime of albumin administration should be established. Secondly, a specific control fluid was not administrated in patients of control group, although the difference in the positive fluid balance between the two groups was not significant. Finally, the sample size after propensity score matching was relatively small, and an expanded population would guarantee an increased statistical power. Therefore, a large randomized controlled study is needed to evaluate the above issues. Conclusion As the first prospective cohort study investigating the association between albumin infusion and incidence of AKI after non-cardiac surgery, the current study did not exhibit benefit of exogenous albumin administration early after non-cardiac surgery on the occurrence of postoperative AKI in patients with a preoperative serum albumin level of less than 37.5g/L. We believe this study will form the basis for further researches in the future. Declarations Ethics approval and consent to participate Ethical approval (2019-075) was provided by the Clinical Research Ethics Committee of Peking University First Hospital. We confirmed that all methods were performed in accordance with relevant guidelines and regulations. Written informed consents were obtained from patients, their next of kin or their legal representatives. Consent for publication Not applicable. Availability of data and materials The datasets are not publicly available, but available from the corresponding author on reasonable request. Competing interests The authors declare that they have no competing interests. Funding The study was funded by the Clinical Research Program of Peking University First Hospital (2019CR09). Authors’ Contributions MY helped design the study, analyze the data, and draft the manuscript. WJZ helped design the study and perform data collection. MX helped design the study and perform data collection. SNZ helped analyze and interpret data. NL helped design the study, perform data collection, analyze data, draft and revise the manuscript. SLL helped design the study and interpret data. All authors have read and approved the manuscript. Acknowledgements The authors gratefully acknowledge Professor Dong-Xin Wang for his suggestions on study design and data analysis. Abbreviations AKI: acute kidney injury; SICU: Surgical Intensive Care Unit; CKD: chronic kidney disease; BMI: body mass index; ASA: American Society of Anesthesiology; SOFA: Sequential Organ Function Assessment; KDIGO: Kidney Disease Improving Global Outcomes; MV: mechanical ventilation; SD: standard deviation; ASD: absolute standard difference; NA, not applicable. References 1. Long T, Helgason D, Helgadottir S, Palsson R, Gudbjartsson T, Sigurdsson G, Indridason O, Sigurdsson M: Acute Kidney Injury After Abdominal Surgery: Incidence, Risk Factors, and Outcome . Anesthesia and analgesia 2016, 122 (6):1912-1920. 2. Li N, Qiao H, Guo JF, Yang HY, Li XY, Li SL, Wang DX, Yang L: Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: a retrospective cohort study . BMC Anesthesiol 2019, 19 (1):171. 3. Lee JH, Jung JY, Park SW, Song IK, Kim EH, Kim HS, Kim JT: Risk factors of acute kidney injury in children after cardiac surgery . Acta Anaesthesiol Scand 2018, 62 (10):1374-1382. 4. Shin KH, Han SB: Early postoperative hypoalbuminemia is a risk factor for postoperative acute kidney injury following hip fracture surgery . Injury 2018, 49 (8):1572-1576. 5. Wei L, Nan L, Shuangling L: Relationship between postoperative immediate serum albumin level and postoperative acute kidney injury after major abdominal surgery in critically ill patients . Chin Crit Care Med 2021, 33 (8):955-961. 6. Kim K, Bang JY, Kim SO, Kim S, Kim JU, Song JG: Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study . J Neurosurg 2018, 128 (4):1115-1122. 7. Li W, Li N, Li S: Relationship between postoperative immediate serum albumin level and postoperative acute kidney injury after major abdominal surgery in critically ill patients . Zhonghua wei zhong bing ji jiu yi xue 2021, 33 (8):955-961. 8. Iglesias J, Abernethy V, Wang Z, Lieberthal W, Koh J, Levine J: Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS . The American journal of physiology 1999, 277 (5):F711-722. 9. Wiedermann C, Joannidis M: Nephroprotective Potential of Human Albumin Infusion: A Narrative Review . Gastroenterology research and practice 2015, 2015 :912839. 10. Horstick G, Lauterbach M, Kempf T, Bhakdi S, Heimann A, Horstick M, Meyer J, Kempski O: Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock . Critical care medicine 2002, 30 (4):851-855. 11. Ha C, Bhagavan N: Novel insights into the pleiotropic effects of human serum albumin in health and disease . Biochimica et biophysica acta 2013, 1830 (12):5486-5493. 12. Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, Choo SJ, Chung CH, Lee JW, Choi IC: Effect of Exogenous Albumin on the Incidence of Postoperative Acute Kidney Injury in Patients Undergoing Off-pump Coronary Artery Bypass Surgery with a Preoperative Albumin Level of Less Than 4.0 g/dl . Anesthesiology 2016, 124 (5):1001-1011. 13. Yu Y, Liu J, Hu B, Wang R, Yang X, Shang X, Wang G, Wang C, Li B, Gong Y et al : Expert consensus on the use of human serum albumin in critically ill patients . Chinese medical journal 2021, 134 (14):1639-1654. 14. Ostermann M, Bellomo R, Burdmann E, Doi K, Endre Z, Goldstein S, Kane-Gill S, Liu K, Prowle J, Shaw A et al : Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference . Kidney international 2020, 98 (2):294-309. 15. Ichai C, Vinsonneau C, Souweine B, Armando F, Canet E, Clec'h C, Constantin J, Darmon M, Duranteau J, Gaillot T et al : Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies) . Anaesthesia, critical care & pain medicine 2016, 35 (2):151-165. 16. Austin P: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples . Statistics in medicine 2009, 28 (25):3083-3107. 17. Poston J, Koyner J: Sepsis associated acute kidney injury . BMJ (Clinical research ed) 2019, 364 :k4891. 18. Boldt J, Suttner S: Plasma substitutes . Minerva anestesiologica 2005, 71 (12):741-758. 19. Renkin E, Tucker V, Rew K, O'Loughlin D, Wong M, Sibley L: Plasma volume expansion with colloids increases blood-tissue albumin transport . The American journal of physiology 1992, 262 :H1054-1067. 20. Anne Julie Frenette, Josée Bouchard, Pascaline Bernier, Annie Charbonneau, Long Thanh Nguyen, Jean-Philippe Rioux, Stéphan Troyanov, Williamson DR: Albumin administration is associated with acute kidney injury in cardiac surgery a propensity score analysis . Critical Care 2014, 18 :602. 21. Cai S, Luo N, Yuan X, He Y, Wu H, Wang Z: Is albumin administration beneficial in early stage of postoperative hypoalbuminemia after gastrointestinal surgery: a prospective randomized control trial . Chinese journal of surgery 2009, 47 (10):744-747. Tables Table 1. Baseline and Preoperative Variables Used for Propensity Score Matching Full cohort (n=247) Matching cohort (n=128) All (n=247) Albumin group (n=130) Control group (n=117) ASD Albumin group (n=64) Control group (n=64) ASD Age (y) 77 (23-99) 74 (27-99) 78 (23-95) 0.106 74 (29-97) 78 (23-95) 0.004 Male sex 144 (58.3%) 73 (56.2%) 71 (60.7%) 0.100 41 (64.1%) 38 (59.4%) 0.103 BMI (kg/m 2 ) 23.0 (14.3-38.5) 22.9 (14.3-37.0) 23.3 (16.6-38.5) 0.183 22.7 (15.2-31.8） 23.1 (17.0-36.2) 0.171 Hypertension 141 (57.1%) 70 (53.8%) 71 (60.7%) 0.140 33 (51.6%) 36 (56.3%) 0.079 T2DM 65 (26.3%) 35 (26.9%) 30 (25.6%) 0.022 18 (28.1%) 15 (23.4%) 0.110 CKD 34 (13.8%) 17 (13.1%) 17 (14.5%) 0.059 9 (14.1%) 11 (17.2%) 0.086 Preoperative albumin (g/L) 33.9 (20.7-37.4) 33.3 (20.7-37.4) 34.6 (21.0-37.4) 0.367 33.8 (25.1-37.4) 33.6 (21.0-37.4) 0.071 ASA classification 0.029 0.000 I-II 35 (14.2%) 18 (13.8%) 17 (14.5%) 10 (15.6%) 10 (15.6%) III-IV 212 (85.8%) 112 (86.2%) 100 (85.5%) 54 (84.4%) 54 (84.4%) Data are presented as mean±SD, median (minimum-maximum) or number (percent). Abbreviations: ASD, absolute standardized difference; BMI, body mass index; T2DM, Type 2 diabetes; CKD, chronic kidney disease; ASA, American Society of Anesthesiologists. Table 2. Intraoperative and Postoperative Variables Used for Propensity Score Matching Full cohort (n=247) Matching cohort (n=128) All (n=247) Albumin group (n=130) Control group (n=117) ASD Albumin group (n=64) Control group (n=64) ASD Site of surgery 0.546 0.157 Abdominopelvic 157 (63.6%) 96 (73.9%) 61 (52.1%) 43 (67.2%) 37 (57.8%) Thoracic 26 (10.5%) 12 (9.2%) 14 (12.0%) 7 (10.9%) 9 (14.1%) Neural 7 (2.8%) 2 (1.5%) 5 (4.3%) 1 (1.6%) 3 (4.7%) Orthopedic 54 (21.9%) 20 (15.4%) 34 (29.0%) 13 (20.3%) 15 (23.4%) other 3 (1.2%) 0 (0.0%) 3 (2.6%) 0 (0.0%) 0 (0.0%) Type of surgery 0.158 0.137 Open 113 (45.7%) 75 (57.7%) 38 (32.5%) 35 (54.7%) 25 (39.1%) Laparoscopic 81 (32.8%) 38 (29.2%) 43 (36.7%) 20 (31.3%) 22 (34.4%) Non-relevant 53 (21.5%) 17 (13.1%) 36 (30.8%) 9 (14.1%) 17 (26.6%) Duration of surgery (min） 195 (29-925) 210 (29-925) 183 (33-783) 0.292 186 (29-715) 183 (33-783) 0.056 Type of anesthesia 0.530 0.141 General 234 (94.7%) 127 (97.7%) 107 (91.5%) 61 (95.3%) 60 (93.8%) Epidural 11 (4.5%) 3 (2.3%) 8 (6.8%) 3 (4.7%) 3 (4.7%) Reginal block 2 (0.8%) 0 (0.0%) 2 (1.7%) 0 (0.0%) 1 (1.6%) Duration of anesthesia (min) 279 (70-1012) 289 (84-1012) 273 (70-859) 0.273 255 (84-802) 275 (70-859) 0.065 Intraoperative hypotension a 138 (55.9%) 87 (66.9%) 51 (43.6%) 0.487 35 (54.7%) 38 (59.4%) 0.080 Intraoperative vasoactive drugs b 151 (61.1%) 88 (67.7%) 63 (53.8%) 0.299 41 (64.1%) 39 (60.9%) 0.062 Intraoperative hypotension (min) 15 (5-345) 20 (5-345) 10 (5-240) 0.177 15 (5-120) 10 (5-240) 0.024 Postoperative albumin (g/L) 29.2 (10.5-41.9) 27.2 (10.5-37.6) 31.4 (18.0-41.9) 0.847 29.3 (19.8-37.6) 30.2 (18.0-38.9) 0.028 Non-renal SOFA 3.0 (0.0-11.0) 3.5 (0.0-11.0) 3.0 (0.0-10.0) 0.523 3.0 (0.0-10.0) 3.0 (0.0-10.0) 0.177 Data are presented as mean±SD, median (minimum-maximum) or number (percent). Abbreviations: ASD, absolute standardized difference; SOFA, sequential organ function assessment. a Indicates intraoperative systolic blood pressure lower than 90mmHg, or lower than the baseline value by more than 30%. b Including dopamine, dobutamine, norepinephrine, ephedrine, phenylephrine, epinephrine and meta-hydroxylamine. Table 3. Perioperative Variables Not Used for Propensity Score Matching Full cohort (n=247) Matching cohort (n=128) All (n=247) Albumin group (n=130) Control group (n=117) P value Albumin group (n=64) Control group (n=64) P value Preoperative comorbidities Coronary heart disease 79 (32.0%) 33 (25.4%) 46 (39.3%) 0.019 20 (31.3%) 19 (29.7%) 0.848 Cerebrovascular disease 44 (17.8%) 26 (20.0%) 18 (15.4%) 0.344 10 (15.6%) 12 (18.8%) 0.639 Preoperative Hb (g/L) 108.5±18.5 108.1±17.8 109.0±19.2 0.723 108.4±16.3 105.0±19.0 0.834 Baseline serum creatinine (μmol/L) 72.6 (18.1-286.8) 71.1 (27.9-286.8) 74.6 (18.1-238.31) 0.151 75.6 (44.7-242.0) 68.11 (18.1-238.3) 0.464 Baseline eGFR [ml/(min·1.73m 2 )] 82.2 (18.8-156.1) 81.5 (22.4-156.1) 82.9 (18.8-134.5) 0.198 81.4 (22.6-132.4) 83.5 (25.0-156.1) 0.637 Preoperative BNP (pg/ml) 92.0 (2.8-1622.0) 86.5 (2.8-1197.0) 99.0 (9.0-1622.0) 0.623 80.0 (9.0-1197.0) 81.0 (9.0-791.0) 0.792 Radiocontrast exposure 25 (10.1%) 15 (11.5%) 10 (8.5%) 0.436 7 (10.9%) 6 (9.4%) 0.770 On ACEI/ARB 41 (16.6%) 14 (10.8%) 27 (23.1%) 0.009 6 (9.4%) 10 (15.6%) 0.285 Intraoperative fluid input (ml) 2350 (500-21800) 2825 (550-21800) 1850 (500-8500) 0.000 2350 (550-8293) 1975 (900-8500) 0.116 Intraoperative artificial colloid (ml) 500 (100-3500) 500 (100-3500) 500 (500-1700) 0.174 500 (100-1500) 500 (500-1700) 0.298 Intraoperative fluid output (ml) 600 (10-8650) 625 (50-8650) 520 (10-2800) 0.096 500 (50-2700) 600 (50-2800) 0.351 Intraoperative estimated blood loss (ml) 100 (5-6000) 100 (5-6000) 100 (5-2000) 0.089 100 (10-1700) 100 (5-2000) 0.669 Sepsis on SICU admission 9 (3.6%) 9 (6.9%) 0 (0.0%) 0.004 0 (0.0%) 0 (0.0%) NA Data are presented as mean±SD, median (minimum-maximum) or number (percent). Abbreviations: Hb, hemoglobin; eGFR, estimated glomerular filtration rate; BNP, type B natriuretic peptide; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; SICU, Surgical Intensive Care Unit; NA, not applicable. Table 4. Primary and Secondary Outcomes of the Study in Matched Patients Total (n=128) Albumin group (n=64) Control group (n=64) P value Postoperative AKI 78 (60.9%) 38 (59.4%) 40 (62.5%) 0.717 Albumin on postoperative day 1 (g/L) 30.6±3.6 31.3±3.4 29.7±3.8 0.008 Positive fluid balance on the day of SICU admission (ml/kg) 34.0 (4.0-337.0) 36.5 (4.0-337.0) 32.0 (4.0-128.0) 0.064 On MV in SICU 62 (48.4%) 30 (46.9%) 32 (50.0%) 0.724 Duration of MV (h) 6 (1-1128) 6 (2-392) 6.5 (1-1128) 0.745 Number of postoperative complications except AKI 0 (0-12) 0 (0-11) 0 (0-12) 0.116 In-hospital mortality 6 (4.7%) 2 (3.1%) 4 (6.3%) 0.676 Length of SICU stay (d) 1.5 (1.0-66.0) 2.0 (1.0-23.0) 1.0 (1.0-66.0) 0.090 Postoperative hospital stay (d) 11 (2-72) 11 (2-72) 11.5 (2-71) 0.778 Data were presented as mean±SD, median (minimum-maximum) or number (percentage). Abbreviations: AKI, acute kidney injury; SICU, Surgical Intensive Care Unit; MV, mechanical ventilation. Additional Declarations No competing interests reported. Supplementary Files TableS1.docx Cite Share Download PDF Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-1131516","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":81500617,"identity":"24c8e5e0-2992-4a80-8f45-e4e027620dad","order_by":0,"name":"Miao Yan","email":"","orcid":"","institution":"Peking University First Hospital","correspondingAuthor":false,"prefix":"","firstName":"Miao","middleName":"","lastName":"Yan","suffix":""},{"id":81500619,"identity":"5c70b1f2-54f1-4ad4-adb5-3094b447b2a0","order_by":1,"name":"Wei-Jie Zhou","email":"","orcid":"","institution":"Peking University First Hospital","correspondingAuthor":false,"prefix":"","firstName":"Wei-Jie","middleName":"","lastName":"Zhou","suffix":""},{"id":81500620,"identity":"8d67b502-46a3-49e2-9baf-107de684af84","order_by":2,"name":"Min Xie","email":"","orcid":"","institution":"Peking University First Hospital","correspondingAuthor":false,"prefix":"","firstName":"Min","middleName":"","lastName":"Xie","suffix":""},{"id":81500621,"identity":"8cd61956-6023-4558-b800-820b4444a97d","order_by":3,"name":"Sai-Nan Zhu","email":"","orcid":"","institution":"Peking University First Hospital","correspondingAuthor":false,"prefix":"","firstName":"Sai-Nan","middleName":"","lastName":"Zhu","suffix":""},{"id":81500622,"identity":"395e81b6-8b62-4f7f-a83c-ab4385b12069","order_by":4,"name":"Nan Li","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAsklEQVRIiWNgGAWjYBACNgYGxgMJQAY/M/PhB8RqYQBrkWxnSzMg2qYDIMLgPI+CBFHK+djPGBx4uMMuz/gwD4MBQ41NNGGH8eQYHEg8k1xsdpj3wAOGY2m5DQS1SPAAtbQxJ247zJdgwNhwmGgt9Ymbm3kMJEjRcjhxAzPRWnjSCoBajifOOAwM5ARi/CLffnjjw59t1Yn9/YcPP/hQY0NYCypIIE35KBgFo2AUjAJcAADZWT1sstgdEAAAAABJRU5ErkJggg==","orcid":"","institution":"Peking University First Hospital","correspondingAuthor":true,"prefix":"","firstName":"Nan","middleName":"","lastName":"Li","suffix":""},{"id":81500623,"identity":"b3a870aa-09b2-44c1-8dca-3fadb9dd016c","order_by":5,"name":"Shuang-Ling Li","email":"","orcid":"","institution":"Peking University First Hospital","correspondingAuthor":false,"prefix":"","firstName":"Shuang-Ling","middleName":"","lastName":"Li","suffix":""}],"badges":[],"createdAt":"2021-12-01 13:44:09","currentVersionCode":2,"declarations":"","doi":"10.21203/rs.3.rs-1131516/v2","doiUrl":"https://doi.org/10.21203/rs.3.rs-1131516/v2","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":23601904,"identity":"a254b4cd-b90e-404b-86d0-bd7c1ab6f900","added_by":"auto","created_at":"2022-07-07 18:49:27","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":67663,"visible":true,"origin":"","legend":"\u003cp\u003eFlowchart of the study.\u003c/p\u003e","description":"","filename":"f1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-1131516/v2/0a9d4a15465e147f6b484cff.jpg"},{"id":23601906,"identity":"8da556de-66dc-4d3a-b286-f9b3b109fb94","added_by":"auto","created_at":"2022-07-07 18:49:35","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":842178,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-1131516/v2/a71687c7-9b1f-4e04-981a-c97faa223b16.pdf"},{"id":23601905,"identity":"1352fa6c-85fb-4aa1-a892-982eb57b9e27","added_by":"auto","created_at":"2022-07-07 18:49:27","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":25672,"visible":true,"origin":"","legend":"","description":"","filename":"TableS1.docx","url":"https://assets-eu.researchsquare.com/files/rs-1131516/v2/eaf08703d7e9e3b7e27a3aa4.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"The Effects of Administration of Exogenous Albumin Early after Non-cardiac Surgery on Postoperative AKI in Patients with Preoperative Hypoalbuminemia: A Prospective Propensity-score Matching Analysis","fulltext":[{"header":"Introduction","content":"\u003cp\u003eAcute kidney injury (AKI) is a common complication after surgery among different patient populations, and postoperative AKI is associated with poor outcomes[1]. In the absence of proven effective treatments for AKI, early recognition of modifiable risk factors and the development of renal protective strategies would be beneficial.\u003c/p\u003e\n\u003cp\u003ePerioperative hypoalbuminemia has proved to be a risk factor for increased incidence of postoperative AKI[2-7]. Renal protective properties of albumin have been shown in amount of clinical and basic studies[8-11]. Serum albumin may play a protective role in the maintenance of effective circulating volume and renal perfusion, preservation of proximal tubular integrity and function, binding of endogenous toxins and nephrotoxic drugs, scavenging and limiting the production of reactive oxygen species, and delivery of protective lysophosphatidic acid. In addition, albumin can improve microcirculatory blood flow and reduce the inflammatory response.\u003c/p\u003e\n\u003cp\u003eIn our previous study, a preoperative serum albumin level of less than 37.5g/L was found to be independently associated with postoperative AKI in patients undergoing non-cardiac surgery[2]. We suppose that correction of hypoalbuminemia may be a reasonable preventive strategy for postoperative AKI. Although administration of exogenous albumin for correcting hypoalbuminemia has been widely used in various clinical settings, there are limited data on whether perioperative albumin intravenous infusion affects the occurrence of postoperative AKI, and its usefulness for organ protection is still a matter of debate[12]. This study was conducted to prospectively evaluate the effect of administration of exogenous albumin early after surgery on postoperative AKI occurrence in patients with preoperative hypoalbuminemia following non-cardiac surgery.\u003c/p\u003e"},{"header":"Methods","content":"\u003cp\u003e\u003cstrong\u003eEthics and consent\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study was a secondary analysis of the database of a previously conducted prospective cohort study\u0026nbsp;investigating the perioperative predictors of AKI following non-cardiac surgery. Ethical approval (2019-075) was provided by the Clinical Research Ethics Committee of Peking University First Hospital. The privacy rights of participants were observed. The original study was conducted in the Surgical Intensive Care Units (SICU) of Peking University First Hospital from May 1, 2019, to November 30, 2020. Written informed consents were obtained from patients, their next of kin or their legal representatives.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePatients\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe inclusion criteria included (1) adult patients (age\u0026ge;18 years), (2) undergoing non-cardiac surgery, and (3) being admitted to SICU immediately after surgery. Patients with any of the following criteria were excluded: (1) preoperative chronic kidney disease stage 5 or requiring long-term dialysis; (2) surgery involving kidney, such as nephrectomy, partial nephrectomy, nephroureterectomy, or kidney transplantation; (3) AKI events before admission to SICU; (4) without Foley catheter placement; and (5) written informed consent not obtained. Our medical center is a teaching hospital affiliated with a university, which provides tertiary care and has about 1600 beds.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData collection\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSpecially trained researchers were responsible for patient recruitment and data collection. The data of patients were collected from the electronic medical records system of our hospital. Preoperative information included demographic characteristics (age, gender), body mass index (BMI), medical history, nephrotoxin exposure, American Society of Anesthesiology (ASA) Classification of Physical Status, as well as preoperative clinical laboratory data. Intraoperative data included type and duration of surgery, surgical approach, anesthesia method, duration of anesthesia, fluid input and output, estimated blood loss, occurrence of hypotension and duration, and use of vasoactive drugs. Postoperative data included non-renal Sequential Organ Function Assessment (SOFA) score within 24h of SICU admission and sepsis on SICU admission.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDefinition and outcomes\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe cutoff value of preoperative hypoalbuminemia was 37.5g/L, which referred to our previous research reporting that preoperative serum albumin level less than 37.5g/L was an independent risk factor for AKI after non-cardiac surgery[2].\u003c/p\u003e\n\u003cp\u003eThe timing of early administration of exogenous albumin was defined as being less than 12 hours after surgery.\u0026nbsp;In our department, 20% albumin is generally administrated either in patients who require persist fluid resuscitation, or in patients who need to maintain a high colloidal osmotic pressure, such as patients with intracranial hypertension or a very low albumin level[13].\u003c/p\u003e\n\u003cp\u003ePostoperative follow-up was performed. The primary end point was postoperative AKI development. Postoperative AKI were defined according to Kidney Disease Improving Global Outcomes (KDIGO) criteria using the maximal change in serum creatinine compared with the preoperative baseline values and urine output during the first 7 postoperative days[14].\u003c/p\u003e\n\u003cp\u003eThe secondary end points were the amount of early albumin infusion, the level of serum albumin on postoperative day 1, positive fluid balance on the day of SICU admission, postoperative use and duration of mechanical ventilation (MV), length of stay in SICU and hospital after surgery, occurrence of postoperative complications other than AKI, and in-hospital mortality. Other main postoperative complications were pulmonary infection, pleural effusion, pulmonary atelectasis, respiratory failure, surgical bleeding, new-onset arrhythmia, acute myocardial infarction, hemodynamic insufficiency, stroke, ileus, anastomotic leakage, intra-abdominal abscess, acute liver injury, wound infection, wound dehiscence, urinary tract infection, sepsis, disseminated intravascular coagulation, digestive tract bleeding, and venous thromboembolism (Table S1).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eStatistical analysis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe Kolmogorov-Smirnov method was used to test the normality of continuous\u0026nbsp;variables. Normally distributed data were presented as mean \u0026plusmn; standard deviation (SD), and non-normally distributed data were presented as median (minimum-maximum).\u0026nbsp;Categorical variables\u0026nbsp;were presented as number (percentage). Analyses of the frequencies of categorical variables were performed using chi-squared test or Fisher\u0026rsquo;s exact test. Differences in quantitative\u0026nbsp;variables\u0026nbsp;between two independent groups were tested with t-test or Mann\u0026ndash;Whitney U test.\u003c/p\u003e\n\u003cp\u003eSeveral underlying susceptibilities, procedures, or exposures have been identified as risk factors of postoperative AKI occurrence[3, 15].Variables being considered clinically relevant were used for propensity score matching and selected a priori. These variables included age, gender, BMI, preoperative comorbidities, preoperative and postoperative albumin, ASA classification, type and duration of surgery, type and duration of anesthesia, intraoperative hemodynamic instability and postoperative non-renal SOFA. The propensity score matching was conducted using multivariate logistic regression. Patients were matched in a 1:1 ratio based on their scores using the nearest-neighbor matching with the tolerance being 0.1. Between-group differences of baseline and perioperative variables for propensity score matching were compared using the absolute standardized differences (ASDs)[16], which were calculated as (mean1-mean2)/SD1. An ASD \u0026ge;0.250\u0026nbsp;\u003cimg src=\"data:image/png;base64,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\"\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ewas considered imbalanced between the two groups.\u003c/p\u003e\n\u003cp\u003eData analyses were performed with SPSS 26.0. Two-tailed \u003cem\u003eP\u003c/em\u003e values lower than 0.05 were considered statistically significant.\u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003e\u003cstrong\u003eParticipants\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDuring the enrollment period, a total of 661 patients who underwent non-cardiac surgery and were admitted to SICU met the inclusion/exclusion criteria. Of the 247 patients with preoperative\u0026nbsp;hypoalbuminemia,\u0026nbsp;130 received administration of 20% albumin early after surgery (albumin group), with 25 (19.2%) receiving albumin for hemodynamic stabilization and improving organ perfusion, 70 (53.8%) receiving albumin to maintain high colloid osmolarity, and 35 (26.9%) receiving albumin for the both aims. The amounts of the received albumin were 20 (10-100) gram, 20 (10-150) gram and 30 (10-50) gram, respectively. The remaining 117 did not receive postoperative early albumin infusion (control group).\u0026nbsp;Propensity score matching was performed to match the baseline and perioperative variables.\u0026nbsp;Ultimately, 64 pairs of patients were included in the final statistical analysis. Figure 1 showed the flow diagram of the study.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBaseline and perioperative data\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn this study, the baseline and perioperative data of the 247 patients with preoperative hypoalbuminemia were analyzed. Compared with patients of the control group, those of the albumin group had more history of coronary heart disease, more ACEI/ARB medication history, lower preoperative and postoperative albumin; they underwent more abdominopelvic surgery and general anesthesia; they had longer duration of surgery and anesthesia; they received more fluids during surgery; they showed more intraoperative hypotension and received more vasoactive drugs; they had higher non-renal SOFA within 24h of SICU admission and more sepsis on SICU admission. After propensity score matching, the above variables of the two groups were well balanced (Tables 1-3).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrimary and secondary endpoints\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe patients of the albumin group were administrated with 20 (10-150) gram albumin early after surgery, and serum albumin on postoperative day 1 in patients of the albumin group was higher than that in patients of the control group [31.3\u0026plusmn;3.4 vs. 29.7\u0026plusmn;3.8, \u003cem\u003eP\u003c/em\u003e=0.008], which indicated that administration of albumin early after surgery did improve the albumin level on postoperative day 1. However, there was no difference in postoperative AKI incidence between the two groups (59.4% vs. 62.5%, \u003cem\u003eP\u003c/em\u003e=0.717). Furthermore, higher positive fluid balance on the day of SICU admission was observed in the albumin group, but not statistically significant [36.5 (4.0-337.0) vs. 32.0 (4.0-128.0), \u003cem\u003eP\u003c/em\u003e=0.064] (Table 4).\u003c/p\u003e\n\u003cp\u003eRegarding other secondary end points, no difference was found in the use and duration of MV, number of other postoperative complications, in-hospital mortality and postoperative hospital stay between the two groups (Table 4). Particularly, the tendency of\u0026nbsp;longer duration of SICU stay in the albumin group\u0026nbsp;was noticed, although no statistical difference was observed [2.0 (1.0-23.0) vs. 1.0 (1.0-66.0), \u003cem\u003eP\u003c/em\u003e=0.090]. As for postoperative complications, the rate of sepsis seemed to be higher in patients of the albumin group (18.8% vs. 6.3%, \u003cem\u003eP\u003c/em\u003e=0.059] (Table S1). One of the most common organs affected by sepsis is the kidney, resulting in sepsis associated AKI that contributes to the morbidity and mortality of sepsis[17]. Sepsis associated AKI was diagnosed in 6 (9.4%) patients of the albumin group, and 2 (3.1%) patients of the control group (\u003cem\u003eP\u003c/em\u003e=0.273). Besides, the rate of acute myocardial infarction was found to be higher in patients of the albumin group (9.4% vs. 0.0%, \u003cem\u003eP\u003c/em\u003e=0.028) (Table S1).\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eIn this study, we prospectively analyzed the association between administration of exogenous albumin early after non-cardiac surgery and postoperative AKI in patients with preoperative hypoalbuminemia. Although the patients of the albumin group exhibited a higher serum albumin level on postoperative day 1, no differences were observed in postoperative AKI occurrence and other prognostic factors between the two groups.\u003c/p\u003e\n\u003cp\u003eCumulative evidence has shown that a perioperatively reduced serum albumin level may contribute to an increased risk of postoperative AKI in various clinical settings[1-4, 6, 7]. There are several factors responsible for the changes in albumin concentration after surgery: (1) Large amounts of fluid infusion during the operation leads to the dilution of plasma albumin; (2) The ability of liver to synthesize albumin decreases under stress; (3) Decomposition of albumin is increased to compensate for energy expenditure under stress; (4) The permeability of capillaries increases in the systemic inflammatory responses, and plasma albumin molecules leak out from the blood vessels; (5) Albumin is lost with blood loss during surgery. Among the above factors, the blood dilution and the exudation of albumin molecules out of the capillaries were considered to be the main causes of postoperative hypoalbuminemia[18, 19].\u003c/p\u003e\n\u003cp\u003eCurrently, the conclusions of limited studies investigating the effect of perioperative exogenous albumin infusion on occurrence of postoperative AKI are not consistent.\u0026nbsp;Eun-Ho Lee et al. prospectively reported that administration of exogenous albumin immediately before surgery reduced the risk of AKI after off-pump coronary artery bypass surgery in patients with a preoperative serum albumin level of less than 4.0 g/dl, although the observed difference in that study was only marginally significant (\u003cem\u003eP\u003c/em\u003e=0.048)[12]. On the contrary, in the retrospective cohort study of Anne Julie Frenette et al, a dose-dependent AKI risk associated with the administration of albumin until 36 hours after surgery was observed in patients undergoing on-pump cardiac surgery[20].\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTo the best of our knowledge, this is the first prospective cohort study investigating the association of albumin infusion early after non-cardiac surgery and incidence of postoperative AKI.\u0026nbsp;In our study, there was no difference in occurrence of postoperative AKI in patients of the two groups, which did not show improvement of administration of exogenous albumin early after non-cardiac surgery on renal outcome. Several reasons were supposed to be responsible for the result. As mentioned above, surgery and the systemic inflammatory responses increase capillary permeability significantly, and massive albumin molecules leak out of the capillaries into the interstitial space, so the effect of correcting the hypoalbuminemia and the renal protective properties of serum albumin would not sustained. From this perspective, administration of exogenous albumin early after surgery, especially for major abdominopelvic surgery, is cost and unhelpful. On the contrary, with the subsidence of systemic inflammatory responses and the optimization of nutritional status, the level of serum albumin tends to recover spontaneously[21]. Additionally, in our study, although exogenous albumin was administrated early after surgery, the level of serum albumin in more than 89% of the patients was still lower than the threshold value, and the possibility that the dosage of exogenous albumin might not be sufficient could not be excluded completely. Furthermore, the causes of postoperative AKI are complicated and multifactorial. The isolated procedure of postoperative administration of exogenous albumin may not be enough to inhibit the pathological process leading to AKI in these high-risk patients.\u003c/p\u003e\n\u003cp\u003eAs for the secondary outcomes,\u0026nbsp;the rate of sepsis seemed to be higher in patients of the albumin group (Table S1). This difference was supposed to be relevant to the higher rate of abdominopelvic surgery (67.2% vs. 57.8%) and open surgery (54.7% vs. 39.1%) in patients of the albumin group (Table 2-3), which predisposed patients to a high risk of infection. Meanwhile, despite propensity score was matched between the two groups, there might be some confounding factors that have not been well balanced and a selective bias might exist. For sepsis associated AKI, there was no statistical difference between the two groups.\u0026nbsp;The incidence rate of acute myocardial infarction was found to be higher in the albumin group (Table S1), which might be explained by the\u0026nbsp;higher rate of preoperative T2DM (28.1% vs. 23.4%) (Table 1) and postoperative sepsis (18.8% vs. 6.3%) in this group of patients.\u0026nbsp;Specially, the higher incidence rates of postoperative complications mentioned above were also the main factors that were responsible for the longer SICU stay in these patients (Table 4).\u003c/p\u003e\n\u003cp\u003eThere are several other shortcomings in this study. Firstly, the standard of timing and dosage of albumin administration was absent. A definite treatment regime of albumin administration should be established. Secondly, a specific control fluid was not administrated in patients of control group, although the difference in the positive fluid balance between the two groups was not significant. Finally, the sample size after propensity score matching was relatively small, and an expanded population would guarantee an increased statistical power. Therefore, a large randomized controlled study is needed to evaluate the above issues.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eAs the first prospective cohort study investigating the association between albumin infusion and incidence of AKI after non-cardiac surgery, the current study did not exhibit benefit of exogenous albumin administration early after non-cardiac surgery on the occurrence of postoperative AKI in patients with a preoperative serum albumin level of less than 37.5g/L. We believe this study will form the basis for further researches in the future.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eEthics approval and consent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eEthical approval (2019-075) was provided by the Clinical Research Ethics Committee of Peking University First Hospital. We confirmed that all methods were performed in accordance with relevant guidelines and regulations. Written informed consents were obtained from patients, their next of kin or their legal representatives.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for publication\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and materials\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets are not publicly available, but available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no competing interests.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe study was funded by the Clinical Research Program of Peking University First Hospital (2019CR09).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors\u0026rsquo; Contributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eMY helped design the study, analyze the data, and draft the manuscript. WJZ helped design the study and perform data collection. MX helped design the study and perform data collection. SNZ helped analyze and interpret data. NL helped design the study, perform data collection, analyze data, draft and revise the manuscript. SLL helped design the study and interpret data. All authors have read and approved the manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors gratefully acknowledge Professor Dong-Xin Wang for\u0026nbsp;his suggestions on study design and data analysis.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cp\u003eAKI: acute kidney injury; SICU: Surgical Intensive Care Unit; CKD: chronic kidney disease; BMI: body mass index; ASA: American Society of Anesthesiology; SOFA: Sequential Organ Function Assessment; KDIGO: Kidney Disease Improving Global Outcomes; MV: mechanical ventilation; SD: standard deviation; ASD: absolute standard difference; NA, not applicable.\u003c/p\u003e"},{"header":"References","content":"\u003cp\u003e1.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Long T, Helgason D, Helgadottir S, Palsson R, Gudbjartsson T, Sigurdsson G, Indridason O, Sigurdsson M: \u003cstrong\u003eAcute Kidney Injury After Abdominal Surgery: Incidence, Risk Factors, and Outcome\u003c/strong\u003e. \u003cem\u003eAnesthesia and analgesia\u0026nbsp;\u003c/em\u003e2016, \u003cstrong\u003e122\u003c/strong\u003e(6):1912-1920.\u003c/p\u003e\n\u003cp\u003e2.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Li N, Qiao H, Guo JF, Yang HY, Li XY, Li SL, Wang DX, Yang L: \u003cstrong\u003ePreoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: a retrospective cohort study\u003c/strong\u003e. \u003cem\u003eBMC Anesthesiol\u0026nbsp;\u003c/em\u003e2019, \u003cstrong\u003e19\u003c/strong\u003e(1):171.\u003c/p\u003e\n\u003cp\u003e3.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Lee JH, Jung JY, Park SW, Song IK, Kim EH, Kim HS, Kim JT: \u003cstrong\u003eRisk factors of acute kidney injury in children after cardiac surgery\u003c/strong\u003e. \u003cem\u003eActa Anaesthesiol Scand\u0026nbsp;\u003c/em\u003e2018, \u003cstrong\u003e62\u003c/strong\u003e(10):1374-1382.\u003c/p\u003e\n\u003cp\u003e4.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Shin KH, Han SB: \u003cstrong\u003eEarly postoperative hypoalbuminemia is a risk factor for postoperative acute kidney injury following hip fracture surgery\u003c/strong\u003e. \u003cem\u003eInjury\u0026nbsp;\u003c/em\u003e2018, \u003cstrong\u003e49\u003c/strong\u003e(8):1572-1576.\u003c/p\u003e\n\u003cp\u003e5.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Wei L, Nan L, Shuangling L: \u003cstrong\u003eRelationship between postoperative immediate serum albumin level and postoperative acute kidney injury after major abdominal surgery in critically ill patients\u003c/strong\u003e. \u003cem\u003eChin Crit Care Med\u0026nbsp;\u003c/em\u003e2021, \u003cstrong\u003e33\u003c/strong\u003e(8):955-961.\u003c/p\u003e\n\u003cp\u003e6.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Kim K, Bang JY, Kim SO, Kim S, Kim JU, Song JG: \u003cstrong\u003eAssociation of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study\u003c/strong\u003e. \u003cem\u003eJ Neurosurg\u0026nbsp;\u003c/em\u003e2018, \u003cstrong\u003e128\u003c/strong\u003e(4):1115-1122.\u003c/p\u003e\n\u003cp\u003e7.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Li W, Li N, Li S: \u003cstrong\u003eRelationship between postoperative immediate serum albumin level and postoperative acute kidney injury after major abdominal surgery in critically ill patients\u003c/strong\u003e. \u003cem\u003eZhonghua wei zhong bing ji jiu yi xue\u0026nbsp;\u003c/em\u003e2021, \u003cstrong\u003e33\u003c/strong\u003e(8):955-961.\u003c/p\u003e\n\u003cp\u003e8.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Iglesias J, Abernethy V, Wang Z, Lieberthal W, Koh J, Levine J: \u003cstrong\u003eAlbumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS\u003c/strong\u003e. \u003cem\u003eThe American journal of physiology\u0026nbsp;\u003c/em\u003e1999, \u003cstrong\u003e277\u003c/strong\u003e(5):F711-722.\u003c/p\u003e\n\u003cp\u003e9.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Wiedermann C, Joannidis M: \u003cstrong\u003eNephroprotective Potential of Human Albumin Infusion: A Narrative Review\u003c/strong\u003e. \u003cem\u003eGastroenterology research and practice\u0026nbsp;\u003c/em\u003e2015, \u003cstrong\u003e2015\u003c/strong\u003e:912839.\u003c/p\u003e\n\u003cp\u003e10.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Horstick G, Lauterbach M, Kempf T, Bhakdi S, Heimann A, Horstick M, Meyer J, Kempski O: \u003cstrong\u003eEarly albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock\u003c/strong\u003e. \u003cem\u003eCritical care medicine\u0026nbsp;\u003c/em\u003e2002, \u003cstrong\u003e30\u003c/strong\u003e(4):851-855.\u003c/p\u003e\n\u003cp\u003e11.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Ha C, Bhagavan N: \u003cstrong\u003eNovel insights into the pleiotropic effects of human serum albumin in health and disease\u003c/strong\u003e. \u003cem\u003eBiochimica et biophysica acta\u0026nbsp;\u003c/em\u003e2013, \u003cstrong\u003e1830\u003c/strong\u003e(12):5486-5493.\u003c/p\u003e\n\u003cp\u003e12.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, Choo SJ, Chung CH, Lee JW, Choi IC: \u003cstrong\u003eEffect of Exogenous Albumin on the Incidence of Postoperative Acute Kidney Injury in Patients Undergoing Off-pump Coronary Artery Bypass Surgery with a Preoperative Albumin Level of Less Than 4.0 g/dl\u003c/strong\u003e. \u003cem\u003eAnesthesiology\u0026nbsp;\u003c/em\u003e2016, \u003cstrong\u003e124\u003c/strong\u003e(5):1001-1011.\u003c/p\u003e\n\u003cp\u003e13.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Yu Y, Liu J, Hu B, Wang R, Yang X, Shang X, Wang G, Wang C, Li B, Gong Y\u003cem\u003e\u0026nbsp;et al\u003c/em\u003e: \u003cstrong\u003eExpert consensus on the use of human serum albumin in critically ill patients\u003c/strong\u003e. \u003cem\u003eChinese medical journal\u0026nbsp;\u003c/em\u003e2021, \u003cstrong\u003e134\u003c/strong\u003e(14):1639-1654.\u003c/p\u003e\n\u003cp\u003e14.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Ostermann M, Bellomo R, Burdmann E, Doi K, Endre Z, Goldstein S, Kane-Gill S, Liu K, Prowle J, Shaw A\u003cem\u003e\u0026nbsp;et al\u003c/em\u003e: \u003cstrong\u003eControversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference\u003c/strong\u003e. \u003cem\u003eKidney international\u0026nbsp;\u003c/em\u003e2020, \u003cstrong\u003e98\u003c/strong\u003e(2):294-309.\u003c/p\u003e\n\u003cp\u003e15.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Ichai C, Vinsonneau C, Souweine B, Armando F, Canet E, Clec\u0026apos;h C, Constantin J, Darmon M, Duranteau J, Gaillot T\u003cem\u003e\u0026nbsp;et al\u003c/em\u003e: \u003cstrong\u003eAcute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)\u003c/strong\u003e. \u003cem\u003eAnaesthesia, critical care \u0026amp; pain medicine\u0026nbsp;\u003c/em\u003e2016, \u003cstrong\u003e35\u003c/strong\u003e(2):151-165.\u003c/p\u003e\n\u003cp\u003e16.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Austin P: \u003cstrong\u003eBalance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples\u003c/strong\u003e. \u003cem\u003eStatistics in medicine\u0026nbsp;\u003c/em\u003e2009, \u003cstrong\u003e28\u003c/strong\u003e(25):3083-3107.\u003c/p\u003e\n\u003cp\u003e17.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Poston J, Koyner J: \u003cstrong\u003eSepsis associated acute kidney injury\u003c/strong\u003e. \u003cem\u003eBMJ (Clinical research ed)\u0026nbsp;\u003c/em\u003e2019, \u003cstrong\u003e364\u003c/strong\u003e:k4891.\u003c/p\u003e\n\u003cp\u003e18.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Boldt J, Suttner S: \u003cstrong\u003ePlasma substitutes\u003c/strong\u003e. \u003cem\u003eMinerva anestesiologica\u0026nbsp;\u003c/em\u003e2005, \u003cstrong\u003e71\u003c/strong\u003e(12):741-758.\u003c/p\u003e\n\u003cp\u003e19.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Renkin E, Tucker V, Rew K, O\u0026apos;Loughlin D, Wong M, Sibley L: \u003cstrong\u003ePlasma volume expansion with colloids increases blood-tissue albumin transport\u003c/strong\u003e. \u003cem\u003eThe American journal of physiology\u0026nbsp;\u003c/em\u003e1992, \u003cstrong\u003e262\u003c/strong\u003e:H1054-1067.\u003c/p\u003e\n\u003cp\u003e20.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Anne Julie Frenette, Jos\u0026eacute;e Bouchard, Pascaline Bernier, Annie Charbonneau, Long Thanh Nguyen, Jean-Philippe Rioux, St\u0026eacute;phan Troyanov, Williamson DR: \u003cstrong\u003eAlbumin administration is associated with acute kidney injury in cardiac surgery a propensity score analysis\u003c/strong\u003e. \u003cem\u003eCritical Care\u0026nbsp;\u003c/em\u003e2014, \u003cstrong\u003e18\u003c/strong\u003e:602.\u003c/p\u003e\n\u003cp\u003e21.\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;Cai S, Luo N, Yuan X, He Y, Wu H, Wang Z: \u003cstrong\u003eIs albumin administration beneficial in early stage of postoperative hypoalbuminemia after gastrointestinal surgery: a prospective randomized control trial\u003c/strong\u003e. \u003cem\u003eChinese journal of surgery\u0026nbsp;\u003c/em\u003e2009, \u003cstrong\u003e47\u003c/strong\u003e(10):744-747.\u003c/p\u003e"},{"header":"Tables","content":"\u003cp\u003eTable 1. Baseline and Preoperative Variables Used for Propensity Score Matching\u003c/p\u003e\n\u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.19191919191919%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.121212121212121%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\" width=\"34.343434343434346%\"\u003e\n \u003cp\u003eFull cohort (n=247)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\" width=\"34.343434343434346%\"\u003e\n \u003cp\u003eMatching cohort (n=128)\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003eAll (n=247)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003eAlbumin group (n=130)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003eControl group (n=117)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003eASD\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003eAlbumin group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003eControl group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003eASD\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eAge (y)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e77 (23-99)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e74 (27-99)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e78 (23-95)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.106\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e74 (29-97)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e78 (23-95)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.004\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eMale sex\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e144 (58.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e73 (56.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e71 (60.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.100\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e41 (64.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e38 (59.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.103\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eBMI (kg/m\u003csup\u003e2\u003c/sup\u003e)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e23.0 (14.3-38.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e22.9 (14.3-37.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e23.3 (16.6-38.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.183\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e22.7 (15.2-31.8）\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e23.1 (17.0-36.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.171\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eHypertension\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e141 (57.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e70 (53.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e71 (60.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.140\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e33 (51.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e36 (56.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.079\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eT2DM\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e65 (26.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e35 (26.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e30 (25.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.022\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e18 (28.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e15 (23.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.110\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eCKD\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e34 (13.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e17 (13.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e17 (14.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.059\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e9 (14.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e11 (17.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.086\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003ePreoperative albumin (g/L)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e33.9 (20.7-37.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e33.3 (20.7-37.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e34.6 (21.0-37.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.367\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e33.8 (25.1-37.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e33.6 (21.0-37.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.071\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eASA classification\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.029\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e0.000\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eI-II\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e35 (14.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e18 (13.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e17 (14.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e10 (15.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e10 (15.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"19.587628865979383%\"\u003e\n \u003cp\u003eIII-IV\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.371134020618557%\"\u003e\n \u003cp\u003e212 (85.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.402061855670103%\"\u003e\n \u003cp\u003e112 (86.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"15.463917525773196%\"\u003e\n \u003cp\u003e100 (85.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e54 (84.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.43298969072165%\"\u003e\n \u003cp\u003e54 (84.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.154639175257732%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eData are presented as mean\u0026plusmn;SD, median (minimum-maximum) or number (percent).\u003c/p\u003e\n\u003cp\u003eAbbreviations: ASD, absolute standardized difference; BMI, body mass index; T2DM, Type 2 diabetes; CKD, chronic kidney disease; ASA, American Society of Anesthesiologists.\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e\n\u003cp\u003eTable 2. Intraoperative and Postoperative Variables Used for Propensity Score Matching\u003c/p\u003e\n\u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\" width=\"32.6530612244898%\"\u003e\n \u003cp\u003eFull cohort (n=247)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\" width=\"31.632653061224488%\"\u003e\n \u003cp\u003eMatching cohort (n=128)\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003eAll (n=247)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003eAlbumin group (n=130)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003eControl group (n=117)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003eASD\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003eAlbumin group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003eControl group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003eASD\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eSite of surgery\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.546\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.157\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eAbdominopelvic\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e157 (63.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e96 (73.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e61 (52.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e43 (67.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e37 (57.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eThoracic\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e26 (10.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e12 (9.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e14 (12.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e7 (10.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e9 (14.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eNeural\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e7 (2.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e2 (1.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e5 (4.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e1 (1.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e3 (4.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eOrthopedic\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e54 (21.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e20 (15.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e34 (29.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e13 (20.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e15 (23.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eother\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e3 (1.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e3 (2.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eType of surgery\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.158\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.137\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eOpen\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e113 (45.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e75 (57.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e38 (32.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e35 (54.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e25 (39.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eLaparoscopic\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e81 (32.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e38 (29.2%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e43 (36.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e20 (31.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e22 (34.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eNon-relevant\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e53 (21.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e17 (13.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e36 (30.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e9 (14.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e17 (26.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eDuration of surgery (min）\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e195 (29-925)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e210 (29-925)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e183 (33-783)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.292\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e186 (29-715)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e183 (33-783)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.056\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eType of anesthesia\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.530\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.141\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eGeneral\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e234 (94.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e127 (97.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e107 (91.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e61 (95.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e60 (93.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eEpidural\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e11 (4.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e3 (2.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e8 (6.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e3 (4.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e3 (4.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eReginal block\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e2 (0.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e2 (1.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e1 (1.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eDuration of anesthesia (min)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e279 (70-1012)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e289 (84-1012)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e273 (70-859)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.273\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e255 (84-802)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e275 (70-859)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.065\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eIntraoperative hypotension \u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e138 (55.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e87 (66.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e51 (43.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.487\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e35 (54.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e38 (59.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.080\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eIntraoperative vasoactive drugs \u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e151 (61.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e88 (67.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e63 (53.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.299\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e41 (64.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e39 (60.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.062\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eIntraoperative hypotension (min)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e15 (5-345)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e20 (5-345)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e10 (5-240)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.177\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e15 (5-120)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e10 (5-240)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.024\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003ePostoperative albumin (g/L)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e29.2 (10.5-41.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e27.2 (10.5-37.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e31.4 (18.0-41.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.847\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e29.3 (19.8-37.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e30.2 (18.0-38.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.028\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"23.46938775510204%\"\u003e\n \u003cp\u003eNon-renal SOFA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e3.0 (0.0-11.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e3.5 (0.0-11.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"12.244897959183673%\"\u003e\n \u003cp\u003e3.0 (0.0-10.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.142857142857143%\"\u003e\n \u003cp\u003e0.523\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"11.224489795918368%\"\u003e\n \u003cp\u003e3.0 (0.0-10.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"14.285714285714286%\"\u003e\n \u003cp\u003e3.0 (0.0-10.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"6.122448979591836%\"\u003e\n \u003cp\u003e0.177\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eData are presented as mean\u0026plusmn;SD, median (minimum-maximum) or number (percent).\u003c/p\u003e\n\u003cp\u003eAbbreviations: ASD, absolute standardized difference; SOFA, sequential organ function assessment.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003eIndicates intraoperative systolic blood pressure lower than 90mmHg, or lower than the baseline value by more than 30%.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u003cem\u003e\u0026nbsp;\u003c/em\u003e\u003c/sup\u003eIncluding dopamine, dobutamine, norepinephrine, ephedrine, phenylephrine, epinephrine and meta-hydroxylamine.\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e\n\u003cp\u003eTable 3. Perioperative Variables\u0026nbsp;Not Used for Propensity Score Matching\u003c/p\u003e\n\u003cdiv align=\"center\"\u003e\n \u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.428571428571427%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.26530612244898%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\" width=\"32.6530612244898%\"\u003e\n \u003cp\u003eFull cohort (n=247)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\" width=\"32.6530612244898%\"\u003e\n \u003cp\u003eMatching cohort (n=128)\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003eAll (n=247)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003eAlbumin group (n=130)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003eControl group (n=117)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e\u003cem\u003eP\u0026nbsp;\u003c/em\u003evalue\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003eAlbumin group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003eControl group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e\u003cem\u003eP\u0026nbsp;\u003c/em\u003evalue\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003ePreoperative comorbidities\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eCoronary heart disease\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e79 (32.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e33 (25.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e46 (39.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.019\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e20 (31.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e19 (29.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.848\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eCerebrovascular disease\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e44 (17.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e26 (20.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e18 (15.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.344\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e10 (15.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e12 (18.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.639\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003ePreoperative Hb (g/L)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e108.5\u0026plusmn;18.5\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e108.1\u0026plusmn;17.8\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e109.0\u0026plusmn;19.2\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.723\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e108.4\u0026plusmn;16.3\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e105.0\u0026plusmn;19.0\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.834\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eBaseline serum creatinine\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e(\u0026mu;mol/L)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e72.6 (18.1-286.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e71.1 (27.9-286.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e74.6 (18.1-238.31)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.151\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e75.6 (44.7-242.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e68.11 (18.1-238.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.464\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eBaseline eGFR [ml/(min\u0026middot;1.73m\u003csup\u003e2\u003c/sup\u003e)]\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e82.2 (18.8-156.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e81.5 (22.4-156.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e82.9 (18.8-134.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.198\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e81.4 (22.6-132.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e83.5 (25.0-156.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.637\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003ePreoperative BNP (pg/ml)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e92.0 (2.8-1622.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e86.5 (2.8-1197.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e99.0 (9.0-1622.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.623\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e80.0 (9.0-1197.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e81.0 (9.0-791.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.792\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eRadiocontrast exposure\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e25 (10.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e15 (11.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e10 (8.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.436\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e7 (10.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e6 (9.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.770\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eOn ACEI/ARB\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e41 (16.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e14 (10.8%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e27 (23.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.009\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e6 (9.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e10 (15.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.285\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eIntraoperative fluid input (ml)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e2350 (500-21800)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e2825 (550-21800)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e1850 (500-8500)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.000\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e2350 (550-8293)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e1975 (900-8500)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.116\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eIntraoperative artificial colloid (ml)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e500 (100-3500)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e500 (100-3500)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e500 (500-1700)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.174\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e500 (100-1500)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e500 (500-1700)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.298\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eIntraoperative fluid output (ml)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e600 (10-8650)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e625 (50-8650)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e520 (10-2800)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.096\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e500 (50-2700)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e600 (50-2800)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.351\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eIntraoperative estimated\u0026nbsp;\u003c/p\u003e\n \u003cp\u003eblood loss (ml)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e100 (5-6000)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e100 (5-6000)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e100 (5-2000)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.089\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e100 (10-1700)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e100 (5-2000)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.669\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"21.875%\"\u003e\n \u003cp\u003eSepsis on SICU admission\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e9 (3.6%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e9 (6.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003e0.004\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"13.541666666666666%\"\u003e\n \u003cp\u003e0 (0.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"5.208333333333333%\"\u003e\n \u003cp\u003eNA\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n \u003c/table\u003e\n\u003c/div\u003e\n\u003cp\u003eData are presented as mean\u0026plusmn;SD, median (minimum-maximum) or number (percent).\u003c/p\u003e\n\u003cp\u003eAbbreviations: Hb, hemoglobin; eGFR, estimated glomerular filtration rate; BNP, type B natriuretic peptide; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; SICU, Surgical Intensive Care Unit; NA, not applicable.\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e\n\u003cp\u003eTable 4. Primary and Secondary Outcomes of the Study in Matched Patients\u003c/p\u003e\n\u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003eTotal (n=128)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003eAlbumin group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003eControl group (n=64)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e\u003cem\u003eP\u003c/em\u003e value\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003ePostoperative AKI\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e78 (60.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e38 (59.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e40 (62.5%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.717\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003eAlbumin on postoperative day 1 (g/L)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e30.6\u0026plusmn;3.6\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e31.3\u0026plusmn;3.4\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e29.7\u0026plusmn;3.8\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.008\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003ePositive fluid balance on the day of SICU admission (ml/kg)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e34.0 (4.0-337.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e36.5 (4.0-337.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e32.0 (4.0-128.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.064\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003eOn MV in SICU\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e62 (48.4%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e30 (46.9%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e32 (50.0%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.724\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003eDuration of MV (h)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e6 (1-1128)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e6 (2-392)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e6.5 (1-1128)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.745\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003eNumber of postoperative complications except AKI\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e0 (0-12)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e0 (0-11)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e0 (0-12)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.116\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003eIn-hospital mortality\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e6 (4.7%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e2 (3.1%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e4 (6.3%)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.676\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003eLength of SICU stay (d)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e1.5 (1.0-66.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e2.0 (1.0-23.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e1.0 (1.0-66.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.090\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\" width=\"39.175257731958766%\"\u003e\n \u003cp\u003ePostoperative hospital stay (d)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"16.49484536082474%\"\u003e\n \u003cp\u003e11 (2-72)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e11 (2-72)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"18.556701030927837%\"\u003e\n \u003cp\u003e11.5 (2-71)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\" width=\"7.216494845360825%\"\u003e\n \u003cp\u003e0.778\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eData were presented as mean\u0026plusmn;SD, median (minimum-maximum) or number (percentage).\u003c/p\u003e\n\u003cp\u003eAbbreviations: AKI, acute kidney injury; SICU, Surgical Intensive Care Unit; MV, mechanical ventilation.\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Hypoalbuminemia, Acute kidney injury, Exogenous albumin infusion","lastPublishedDoi":"10.21203/rs.3.rs-1131516/v2","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-1131516/v2","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground: \u003c/strong\u003eEvidence has shown that preoperative hypoalbuminemia is independently associated with acute kidney injury (AKI) after non-cardiac surgery. However, little study has investigated the effects of administration of exogenous albumin early after non-cardiac surgery on postoperative AKI in patients with preoperative hypoalbuminemia.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eMethods:\u003c/strong\u003e This study was a secondary analysis of the database of a previously conducted prospective cohort study. Data of 661 adult patients who underwent non-cardiac surgery and were admitted to Surgical Intensive Care Unit (SICU) after surgery from May 1, 2019, to November 30, 2020, were collected. 267 patients with preoperative hypoalbuminemia were screened, and divided into two groups according to whether they were administrated with exogenous albumin on the day of SICU admission. The demographic and perioperative data of the two groups were propensity-matched.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eResults：\u003c/strong\u003eAfter propensity score matching, 64 pairs of patients were included in the final analysis. The patients of the albumin group showed a higher serum albumin level on postoperative day 1 than that in patients of the control group [31.3±3.4 vs. 29.7±3.8, \u003cem\u003eP\u003c/em\u003e=0.008], however, no difference was observed in postoperative AKI incidence between the two groups (59.4% vs. 62.5%, \u003cem\u003eP\u003c/em\u003e=0.717). Furthermore, there was no difference in other prognostic factors, such as the use and duration of mechanical ventilation, number of other postoperative complications, in-hospital mortality, length of SICU stay and postoperative hospital stay.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eConclusions:\u003c/strong\u003e The current study did not exhibit benefit of exogenous albumin administration early after non-cardiac surgery on the occurrence of postoperative AKI in patients with preoperative hypoalbuminemia, which needs to be confirmed by further large randomized controlled researches in the future.\u003c/p\u003e","manuscriptTitle":"The Effects of Administration of Exogenous Albumin Early after Non-cardiac Surgery on Postoperative AKI in Patients with Preoperative Hypoalbuminemia: A Prospective Propensity-score Matching Analysis","msid":"","msnumber":"","nonDraftVersions":[{"code":2,"date":"2022-07-07 18:49:25","doi":"10.21203/rs.3.rs-1131516/v2","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}},{"code":1,"date":"2021-12-08 21:22:50","doi":"10.21203/rs.3.rs-1131516/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"78a5a9b3-14d6-4327-9911-dc6b8175374a","owner":[],"postedDate":"July 7th, 2022","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2022-07-01T06:44:13+00:00","versionOfRecord":[],"versionCreatedAt":"2022-07-07 18:49:25","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v2","identity":"rs-1131516","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-1131516","identity":"rs-1131516","version":["v2"]},"buildId":"_2-kVJe1T_tPrBINL-cwx","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}